Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Efficacy of Lanreotide Depot/Autogel for Symptomatic Control of Carcinoid Syndrome (CS) in Neuroendocrine Tumor Patients: Follow-up Analysis of the ELECT Prospective, Randomized, Double-blind and Open-label Phases Fisher, G. A., Wolin, E. M., Kunz, P. L., Liyanage, N., Mirakhur, B., Lowenthal, S., Pommier, R. F., Shaheen, M., Vinik, A. LIPPINCOTT WILLIAMS & WILKINS. 2017: 433–34
View details for Web of Science ID 000394448600052